Trial
NCT05415917
Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Rutgers, The State University of New Jersey
Collaborators
—
Condition
Pancreatic Cancer
Intervention
Gemcitabine and Capecitabine
Why stopped
No patients enrolled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-07